Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia

The Rat Brain in Stereotaxic Coordinates

1982 • 53,055 citations

Guide for the Care and Use of Laboratory Animals

2011 • 15,863 citations

The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions

2003 • 5,516 citations

What are the functional consequences of neurocognitive deficits in schizophrenia?

1996 • 3,505 citations

Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia

2002 • 2,577 citations

Function and Regulation of CREB Family Transcription Factors in the Nervous System

2002 • 2,037 citations

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

2001 • 1,479 citations

Discovering the Neural Basis of Human Social Anxiety: A Diagnostic and Therapeutic Imperative

2004 • 1,429 citations

Second-Generation (Atypical) Antipsychotics and Metabolic Effects

2005 • 1,335 citations

The Neuropsychopharmacology of Phencyclidine From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia

1999 • 1,300 citations

D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons

2007 • 1,125 citations

Neurocognitive Effects of Antipsychotic Medications in Patients With Chronic Schizophrenia in the CATIE Trial

2007 • 1,036 citations

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

2007 • 1,021 citations

Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis

2006 • 897 citations

Glutamate and Schizophrenia: Phencyclidine, N‐Methyl‐d‐Aspartate Receptors, and Dopamine–Glutamate Interactions

2007 • 543 citations

Institute of Laboratory Animal Resources.

1995 • 459 citations

Startle response models of sensorimotor gating and habituation deficits in schizophrenia

1990 • 457 citations

Glutamate, Dopamine, and Schizophrenia

2003 • 435 citations

Inbred strain differences in prepulse inhibition of the mouse startle response

1997 • 385 citations

Neurobiology of Dopamine in Schizophrenia

2007 • 359 citations

Immunohistochemical localization of PDE10A in the rat brain

2003 • 333 citations

Inhibition of the striatum-enriched phosphodiesterase PDE10A: A novel approach to the treatment of psychosis

2006 • 267 citations

Immunohistochemical Localization of Phosphodiesterase 10A in Multiple Mammalian Species

2006 • 240 citations

Arterial Stiffness and Stroke in Hypertension

2005 • 231 citations

The Selective α7 Nicotinic Acetylcholine Receptor Agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide Hydrochloride] Enhances GABAergic Synaptic Activity in Brain Slices and Restores Auditory Gating Deficits in Anesthetized Rats

2004 • 223 citations

Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: Evidence for altered striatal function

2006 • 223 citations

Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability

1995 • 222 citations

Preattentional and attentional cognitive deficits as targets for treating schizophrenia

2004 • 213 citations

Coordinated Accumbal Dopamine Release and Neural Activity Drive Goal-Directed Behavior

2007 • 207 citations

Cellular and subcellular localization of PDE10A, a striatum-enriched phosphodiesterase

2006 • 191 citations

The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics?

1999 • 186 citations

Neuropharmacology of Phencyclidine: Basic Mechanisms and Therapeutic Potential

1990 • 160 citations

The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity

2002 • 144 citations

Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: a model for detecting antipsychotic activity?

2001 • 126 citations

Auditory sensory gating in hippocampus and reticular thalamic neurons in anesthetized rats

2003 • 123 citations

Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community

2007 • 117 citations

Differential Effects of Direct and Indirect Dopamine Agonists on Prepulse Inhibition: A Study in D1 and D2 Receptor Knock-Out Mice

2002 • 112 citations

Dopamine D1 Rather than D2 Receptor Agonists Disrupt Prepulse Inhibition of Startle in Mice

2003 • 107 citations

Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo

1986 • 106 citations

Effects of the mGluR2/3 agonist LY379268 on ketamine-evoked behaviours and neurochemical changes in the dentate gyrus of the rat

2006 • 63 citations

Dopamine D1 receptor stimulation but not dopamine D2 receptor stimulation attenuates haloperidol-induced behavioral supersensitivity and receptor up-regulation

1993 • 28 citations

Modulation of Neuroleptic Activity of 9,10-Didehydro-N-methyl-(2-propynyl)-6-methyl-8-aminomethylergoline Bimaleinate (LEK-8829) by D1 Intrinsic Activity in Hemi-Parkinsonian Rats

2002 • 12 citations

Pde10a

2006 • 10 citations

PDE10A: A Striatum-Enriched, Dual-Substrate Phosphodiesterase

2006 • 7 citations